Understood
This website is using cookies. More details
NEWS

BioMedomics COVID-19 IgM/IgG Rapid test

BioMedomics has developed and launched one of the world’s first rapid point-of-care lateral flow immunoassays for the diagnosis of coronavirus infection...

OXFORD BIOSYSTEMS and BIOMEDOMICS™ sign exclusive distribution agreement for UK

Founded in 2007, BioMedomics is a privately-held clinical diagnostics company in North Carolina, USA. Their researchers combine biology, biochemistry and...

Orion Diagnostica announce a change to their company name!

Orion Diagnostica are manufacturers of the UniQ product range, including the PIIINP RIA kit, and the microbiology products Hygicult, Uricult, Easicult...

SD Biosensor Standard Q products for COVID-19

SD Biosensor Standard Q products for COVID-19

The Standard Q range of products provides various rapid test parameters with high sensitivity and specificity due to quality control from raw material development to final assay production. The new Antigen and Antibody detection kits for COVID-19 have been developed for point of care use to aid in the management of the COVID-19 pandemic.

Standard Q COVID-19 Ag kit

The Standard Q COVID-19 Ag test is a rapid chromatographic immunoassay for the qualitative detection of specific nucleoprotein antigens to SARS-CoV-2 present in the human nasopharynx. It is a screening test to detect active infection and aid in patient management and infection control.

Performance characteristics were established in a prospective study using 202 nasopharyngeal swabs from symptomatic patients in Malaysia. Results were compared to a those obtained using a commercial molecular test and sensitivity was shown to be 84.38%.


Standard Q COVID-19 Ag kit

This kit is provided for Professional Use only in the UK and Republic of Ireland.

Instructions for use and interpretation of results are provided in the kit.


Please contact us for additional information.

Standard Q COVID-19 IgM/IgG Combo kit

The Standard Q COVID-19 IgM/IgG Combo test is a rapid chromatographic immunoassay for the qualitative detection of specific antibodies to SARS-CoV-2 present in human serum, plasma or whole blood. This test is intended to act as an aid in the diagnosis of SARS-CoV-2 infection in the convalescent phase of a patient with clinical symptoms of SARS-CoV-2 infection. It is designed as an initial screening test to detect past exposure to the SARS-CoV-2 virus and identify susceptible individuals. The use of this test may facilitate contact tracing and surveillance of the infection.


Standard Q COVID-19 IgM/IgG Combo kit

This kit is provided for Professional Use only in the UK and Republic of Ireland.

Instructions for use and interpretation of results are provided in the kit.


Please contact us for additional information.

Oxford Biosystems

184B Park Drive

Milton Park

Abingdon

Oxon

OX14 4SE

Oxford Biosystems has pledged to be an Antibiotic Guardian

Members of:

BIVDA Member 2020 IBMS member